| Followers | 2543 |
| Posts | 250732 |
| Boards Moderated | 34 |
| Alias Born | 05/06/2014 |
Thursday, August 25, 2016 12:51:18 PM
$PMCB PharmaCyte Biotech, Inc. (OTC: PMCB) : At these levels, this could be an incredible GROUND-FLOOR trading opportunity!
Traders are always on the hunt for undiscovered biotech stocks that could be potential acquisition targets or are close to releasing positive results from trials. These stocks can see HUGE explosions on such news!
PMCB is a clinical stage biotechnology company that could revolutionize the way we treat cancer and diabetes!
The company has a technology that could really shake up the medical world and at current levels this could be a STEAL!
PharmaCyte Biotech, Inc. (OTC: PMCB)
Last year shares of PMCB were trading roughly 9 times higher than current levels!
Trading at just around a dime, the stock could be a needle in the market’s haystack. As more people find out what the company is involved with, these levels could blast off!
PMCB is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box®.
This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built.
Pancreas cancer is one of the hardest cancers to detect early on. By the time you’re given the diagnosis, it’s almost always too late. By 2030, pancreas cancer could rise to number two on the list of leading cancer-related deaths. It is a silent killer and most of the time symptoms began to show when the disease is already in stage 4.
PMCB’s treatment for pancreatic cancer involves low doses of the well-known anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or “cancer-killing” form.
These capsules are placed as close to the tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer!
This “targeted chemotherapy” has proven remarkably effective in past clinical trials!
The cancer treatment of Cell-in-a-Box® plus low doses of the anticancer drug ifosfamide was able to produce “complete tumor remission in all animals” that received the treatment on days 2-6 of a previously published preclinical study.
It was a study that used a colon cancer model to treat malignant ascites, a fluid that is common with abdominal cancers like pancreatic, colon, ovarian and liver cancer that accumulates in the abdominal cavity and causes painful swelling of the stomach.
In addition, PMCB is also working towards improving the quality of life for patients with advanced pancreatic cancer and on treatments for other types of solid cancerous tumors.
Cancer affects hundreds of thousands of individuals worldwide every year making the market and need for PMCB’s technology dire.
Finding out about companies like this that can redefine medicine and can save lives could lead to huge profits.
Last year ICPT shares nearly quadrupled in only one day after the company’s drug to treat liver disease caused by fat buildup was found effective in a trial!
It seems almost unheard of that PMCB with their technology is UNDER 10 CENTS!
With everything PMCB is doing, it wouldn’t be surprising if it becomes a major buy out target one day.
The company has also brought together an international group of leading experts to work on their diabetes project. The project involves diabetes treatment and getting that treatment into the hands of insulin-dependent patients around the world.
These experts have become known collectively as the “International Diabetes Consortium.”
What PMCB has accomplished with the 16-member Diabetes Consortium is to essentially speed up the time it will take to get the company’s diabetes treatment into human clinical trials.
With millions of people suffering from diabetes, the company would have a remarkable market.
It’s imperative to keep a close eye on PMCB’s news for any developments on this and their other endeavors! Positive news could be the catalyst needed for a major rally.
Make sure PMCB is on your radar.. the stock could be on the verge of being discovered by the Street.
At these levels, this could be an incredible GROUND-FLOOR trading opportunity!
Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewers entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment.
We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud atwww.investor.gov.In addition, FINRA has published information at its website on how to invest carefully atwww.finra.org/Investors/index.htm
Traders are always on the hunt for undiscovered biotech stocks that could be potential acquisition targets or are close to releasing positive results from trials. These stocks can see HUGE explosions on such news!
PMCB is a clinical stage biotechnology company that could revolutionize the way we treat cancer and diabetes!
The company has a technology that could really shake up the medical world and at current levels this could be a STEAL!
PharmaCyte Biotech, Inc. (OTC: PMCB)
Last year shares of PMCB were trading roughly 9 times higher than current levels!
Trading at just around a dime, the stock could be a needle in the market’s haystack. As more people find out what the company is involved with, these levels could blast off!
PMCB is focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box®.
This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built.
Pancreas cancer is one of the hardest cancers to detect early on. By the time you’re given the diagnosis, it’s almost always too late. By 2030, pancreas cancer could rise to number two on the list of leading cancer-related deaths. It is a silent killer and most of the time symptoms began to show when the disease is already in stage 4.
PMCB’s treatment for pancreatic cancer involves low doses of the well-known anticancer prodrug ifosfamide, together with encapsulated live cells, which convert ifosfamide into its active or “cancer-killing” form.
These capsules are placed as close to the tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer!
This “targeted chemotherapy” has proven remarkably effective in past clinical trials!
The cancer treatment of Cell-in-a-Box® plus low doses of the anticancer drug ifosfamide was able to produce “complete tumor remission in all animals” that received the treatment on days 2-6 of a previously published preclinical study.
It was a study that used a colon cancer model to treat malignant ascites, a fluid that is common with abdominal cancers like pancreatic, colon, ovarian and liver cancer that accumulates in the abdominal cavity and causes painful swelling of the stomach.
In addition, PMCB is also working towards improving the quality of life for patients with advanced pancreatic cancer and on treatments for other types of solid cancerous tumors.
Cancer affects hundreds of thousands of individuals worldwide every year making the market and need for PMCB’s technology dire.
Finding out about companies like this that can redefine medicine and can save lives could lead to huge profits.
Last year ICPT shares nearly quadrupled in only one day after the company’s drug to treat liver disease caused by fat buildup was found effective in a trial!
It seems almost unheard of that PMCB with their technology is UNDER 10 CENTS!
With everything PMCB is doing, it wouldn’t be surprising if it becomes a major buy out target one day.
The company has also brought together an international group of leading experts to work on their diabetes project. The project involves diabetes treatment and getting that treatment into the hands of insulin-dependent patients around the world.
These experts have become known collectively as the “International Diabetes Consortium.”
What PMCB has accomplished with the 16-member Diabetes Consortium is to essentially speed up the time it will take to get the company’s diabetes treatment into human clinical trials.
With millions of people suffering from diabetes, the company would have a remarkable market.
It’s imperative to keep a close eye on PMCB’s news for any developments on this and their other endeavors! Positive news could be the catalyst needed for a major rally.
Make sure PMCB is on your radar.. the stock could be on the verge of being discovered by the Street.
At these levels, this could be an incredible GROUND-FLOOR trading opportunity!
Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewers entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment.
We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the SEC. The SEC has launched an investor-focused website to help you invest wisely and avoid fraud atwww.investor.gov.In addition, FINRA has published information at its website on how to invest carefully atwww.finra.org/Investors/index.htm
investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
